These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 26612221)

  • 21. The prognostic value of the pT-category after combination chemotherapy for patients with invasive bladder cancer who underwent cystectomy. EORTC-GU group.
    Splinter TA; Scher HI; Denis L; Bukowski R; Soloway M; Vogelzang N; Klimberg I; Dalesio O; Herr H
    Prog Clin Biol Res; 1990; 353():219-24. PubMed ID: 2217422
    [No Abstract]   [Full Text] [Related]  

  • 22. Delayed local recurrence following radiation therapy for muscle-invasive bladder cancer emphasizing the need for lifelong surveillance: a case report.
    Sunkara R; Ayyathurai R; Nieder A; Manoharan M
    ScientificWorldJournal; 2008 Feb; 8():166-8. PubMed ID: 18301817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overstaging of transitional cell carcinoma: clinical significance of lamina propria fat within the urinary bladder.
    Bochner BH; Nichols PW; Skinner DG
    Urology; 1995 Mar; 45(3):528-31. PubMed ID: 7879346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined modality treatment with bladder preservation for muscle invasive bladder cancer.
    Sabaa MA; El-Gamal OM; Abo-Elenen M; Khanam A
    Urol Oncol; 2010; 28(1):14-20. PubMed ID: 18818110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
    Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S
    BJU Int; 2013 Oct; 112(6):729-34. PubMed ID: 23790129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Conservative treatment with chemotherapy and radiotherapy in bladder cancer invading the muscle: preliminary results of a prospective study].
    Zapatero A; Pinar B; Arellano R; López M; Marín A; Jiménez U; Pérez Torrubia A
    Arch Esp Urol; 1997 Jun; 50(5):448-54; discussion 454-6. PubMed ID: 9382586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bladder cancer: a review of diagnosis and management.
    Metts MC; Metts JC; Milito SJ; Thomas CR
    J Natl Med Assoc; 2000 Jun; 92(6):285-94. PubMed ID: 10918764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Current status of the conservative treatment of urinary bladder for invasive bladder cancer].
    Ueda K; Sakagami H; Kato F; Mogami T; Ohtaguro K
    Hinyokika Kiyo; 1991 Dec; 37(12):1597-9. PubMed ID: 1785380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An organ-sparing treatment using combined intra-arterial chemotherapy and radiotherapy for muscle-invading bladder carcinoma.
    Tsukamoto S; Ishikawa S; Tsutsumi M; Nakajima K; Sugahara S
    Scand J Urol Nephrol; 2002; 36(5):339-43. PubMed ID: 12487737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The case for neoadjuvant chemotherapy and cystectomy for muscle invasive bladder cancer.
    deVere White RW; Katz MH; Steinberg GD
    J Urol; 2009 May; 181(5):1994-7. PubMed ID: 19286209
    [No Abstract]   [Full Text] [Related]  

  • 31. [Update of the Clinical Guidelines of the European Association of Urology on muscle-invasive and metastatic bladder carcinoma].
    Stenzl A; Cowan NC; De Santis M; Jakse G; Kuczyk MA; Merseburger AS; Ribal MJ; Sherif A; Witjes JA;
    Actas Urol Esp; 2010 Jan; 34(1):51-62. PubMed ID: 20223133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SEOM Clinical Guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2016).
    Lázaro M; Gallardo E; Doménech M; Pinto Á; González-del-Alba A; Del Alba AG; Puente J; Fernández O; Font A; Lainez N; Vázquez S
    Clin Transl Oncol; 2016 Dec; 18(12):1197-1205. PubMed ID: 27900539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prognostic factors in urothelial carcinoma].
    Vögeli TA; Ackermann R
    Urologe A; 2001 Nov; 40(6):442-6. PubMed ID: 11760346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis and treatment of bladder cancer.
    Sharma S; Ksheersagar P; Sharma P
    Am Fam Physician; 2009 Oct; 80(7):717-23. PubMed ID: 19817342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factors in T1 bladder urothelial carcinoma: the value of recording millimetric depth of invasion, diameter of invasive carcinoma, and muscularis mucosa invasion.
    Brimo F; Wu C; Zeizafoun N; Tanguay S; Aprikian A; Mansure JJ; Kassouf W
    Hum Pathol; 2013 Jan; 44(1):95-102. PubMed ID: 22939956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contemporary management of stage T1 transitional cell carcinoma of the bladder.
    Soloway MS; Sofer M; Vaidya A
    J Urol; 2002 Apr; 167(4):1573-83. PubMed ID: 11912367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diagnosis and substaging of pT1 bladder cancer].
    Cheng L; Huang WB; Zheng SQ; Zheng J
    Zhonghua Bing Li Xue Za Zhi; 2007 Sep; 36(9):636-9. PubMed ID: 18070458
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
    Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Update uro-oncology: scientific meetings 2011].
    Hegele A; Skrobek L; Schrader AJ
    Aktuelle Urol; 2012 Jan; 43(1):13-27. PubMed ID: 22344822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.